Advisor
Eli Lilly and Company
Fishers, Indiana
Rachna Chaddha, Msc, Advisor, Eli Lilly and Company, Indianapolis Indiana
Rachna is a results-driven pharmaceutical scientist with over 25 years of experience in Analytical Research and Development. Currently serving as an Advisor at Eli Lilly and Company in Indianapolis, Indiana, she provides strategic analytical support for synthetic molecule drug products, leading method development, validation, lifecycle improvements, and regulatory submissions.
Rachna holds an M.Sc. in Analytical Chemistry and is currently pursuing a Ph.D. in Analytical Chemistry at Indiana University Bloomington, focusing on protein characterization using LC/MS under Professor David Clemmer.
Her career spans distinguished roles at Eurofins Lancaster Laboratories, Sun Pharmaceuticals (formerly Ranbaxy), Teva Pharmaceuticals, and Dabur Research Foundation. She has deep expertise in HPLC/UPLC method development, impurity profiling, ICH-aligned validation, and regulatory compliance across ANDA, NDA, and First-to-File submissions.
Rachna is a published scientist, with peer-reviewed contributions on HPLC-based detection and quantitation of metal ions using evaporative light scattering detection. She is recognized for her leadership in mentoring scientific teams, driving operational excellence, and advancing analytical stewardship across global manufacturing operations.
Disclosure information not submitted.
A Comparative Analytical Framework for NDA and ANDA Submissions
Wednesday, July 15, 2026
9:35 AM - 10:05 AM East Coast USA Time